Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
NCT00837434Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2009
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, adalimumab in rheumatoid arthritis (RA), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2009; status: completed.
02
Drugs
etanerceptadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00837434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837434.